Five advanced pancreatic cancer patients in a Phase I study of anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (BATS)

Five advanced pancreatic cancer patients in a Phase I study of anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (BATS)

Bibliographic Details
Main Authors:	Lum, Lawrence G, Choi, Minsig, Thakur, Archana, Deol, Abhinav, Fields, Kristie, Tomaszewski, Elyse, Schalk, Dana, Kondadasule, Vidya, Dyson, Greg, Mahaseth, Hemchandra, Philip, Philip, Shields, Anthony
Format:	Online
Language:	English
Published:	BioMed Central 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645487/

Similar Items

Ipilimumab augments antitumor activity of bispecific antibody-armed T cells
by: Yano, Hiroshi, et al.
Published: (2014)

Vaccination with bispecific antibody armed T cells (BATC) in metastatic breast cancer patients and transfer of anti-breast cancer immunity in primed T cells after stem cell transplant: a proof of principle study
by: Thakur, Archana, et al.
Published: (2015)

In Situ immunization by bispecific antibody targeted T cell therapy in breast cancer
by: Thakur, Archana, et al.
Published: (2015)

Phase I Study of Anti-CD3 x Anti-Her2 Bispecific Antibody in Metastatic Castrate Resistant Prostate Cancer Patients
by: Vaishampayan, Ulka, et al.
Published: (2015)

Microenvironment generated during EGFR targeted killing of pancreatic tumor cells by ATC inhibits myeloid-derived suppressor cells through COX2 and PGE2 dependent pathway
by: Thakur, Archana, et al.
Published: (2013)

Targeting and killing of glioblastoma with activated T cells armed with bispecific antibodies
by: Zitron, Ian M, et al.
Published: (2013)

In vitro and in vivo stability and anti-tumour efficacy of an anti-EGFR/anti-CD3 F(ab')2 bispecific monoclonal antibody.
by: Negri, D. R., et al.
Published: (1995)

Targeted cancer immunotherapy via combination of designer bispecific antibody and novel gene-engineered T cells
by: Urbanska, Katarzyna, et al.
Published: (2014)

Maspin expression in prostate tumor elicits host anti-tumor immunity
by: Dzinic, Sijana H., et al.
Published: (2014)

Costimulatory T cell engagement via a novel bispecific anti-CD137 /anti-HER2 protein
by: Hinner, Marlon J, et al.
Published: (2015)

Coupling Gd-DTPA with a bispecific, recombinant protein anti-EGFR-iRGD complex improves tumor targeting in MRI
by: XIN, XIAOYAN, et al.
Published: (2016)

Anti-tumoral, anti-angiogenic and anti-metastatic efficacy of a tetravalent bispecific antibody (TAvi6) targeting VEGF-A and angiopoietin-2
by: Scheuer, Werner, et al.
Published: (2016)

Pan-Bcl-2 Inhibitor AT-101 Enhances Tumor Cell Killing by EGFR Targeted T Cells
by: Thakur, Archana, et al.
Published: (2012)

Targeting of saporin to CD25-positive normal and neoplastic lymphocytes by an anti-saporin/anti-CD25 bispecific monoclonal antibody: in vitro evaluation.
by: Tazzari, P. L., et al.
Published: (1993)

Improvement of the Targeting of Radiolabeled and Functionalized Liposomes with a Two-Step System Using a Bispecific Monoclonal Antibody (Anti-CEA × Anti-DTPA–In)
by: Rauscher, Aurore, et al.
Published: (2015)

Bispecific antibodies and their applications
by: Fan, Gaowei, et al.
Published: (2015)

Homogeneous Bispecifics by Disulfide Bridging
by: Hull, Elizabeth A., et al.
Published: (2014)

Generation of chimeric bispecific G250/anti-CD3 monoclonal antibody, a tool to combat renal cell carcinoma.
by: Luiten, R. M., et al.
Published: (1996)

FGF21 Can Be Mimicked In Vitro and In Vivo by a Novel Anti-FGFR1c/β-Klotho Bispecific Protein
by: Smith, Richard, et al.
Published: (2013)

Anti-CD22/CD20 Bispecific Antibody with Enhanced Trogocytosis for Treatment of Lupus
by: Rossi, Edmund A., et al.
Published: (2014)

Effects of different interchain linkers on biological activity of an anti-prostate cancer single-chain bispecific antibody
by: Hao, Chao-hui, et al.
Published: (2015)

Improved anti-leukemia activities of adoptively transferred T cells expressing bispecific T-cell engager in mice
by: Liu, X, et al.
Published: (2016)

Functional comparison of single-chain and two-chain anti-CD3-based bispecific antibodies in gene immunotherapy applications
by: Compte, Marta, et al.
Published: (2014)

Prospective Design of Anti‐Transferrin Receptor Bispecific Antibodies for Optimal Delivery into the Human Brain
by: Kanodia, JS, et al.
Published: (2016)

Overcoming the Constraints of Anti-HIV/CD89 Bispecific Antibodies That Limit Viral Inhibition
by: Yu, Xiaocong, et al.
Published: (2016)

Prospects for Anti-Biofilm Pharmaceuticals
by: Stewart, Philip S.
Published: (2015)

Biguanides and targeted anti-cancer treatments
by: Hanly, Elyse K., et al.
Published: (2015)

BEAT® the bispecific challenge: a novel and efficient platform for the expression of bispecific IgGs
by: Moretti, Pierre, et al.
Published: (2013)

Radiographic Parameters in Predicting Outcome of Patients with Hepatocellular Carcinoma Treated with Yttrium-90 Microsphere Radioembolization
by: Salem, Mohamed E., et al.
Published: (2013)

Bispecific costimulatory molecules for activation of tumor-killing lymphocytes
by: Weth, R, et al.
Published: (2004)

Generation of bispecific monoclonal antibodies for two phase radioimmunotherapy.
by: Bosslet, K., et al.
Published: (1991)

Enhanced antigen immunogenicity induced by bispecific antibodies
Published: (1990)

The role of apoptosis in bispecific antibody-mediated T-cell cytotoxicity.
by: Kroesen, B. J., et al.
Published: (1996)

Engineering Bispecificity into a Single Albumin-Binding Domain
by: Nilvebrant, Johan, et al.
Published: (2011)

Quantification of cell surface proteins with bispecific antibodies
by: Panke, C., et al.
Published: (2013)

Generation and characterization of monospecific and bispecific hexavalent trimerbodies
by: Blanco-Toribio, Ana, et al.
Published: (2013)

Design and Applications of Bispecific Heterodimers: Molecular Imaging and beyond
by: Luo, Haiming, et al.
Published: (2014)

The development of bispecific antibodies and their applications in tumor immune escape
by: Xiaolong Zhang, et al.
Published: (2017-05-01)

Engineering IgG-Like Bispecific Antibodies—An Overview
by: Simon Krah, et al.
Published: (2018-08-01)

The application of mathematical modelling to the design of bispecific monoclonal antibodies
by: van Steeg, Tamara J., et al.
Published: (2016)